Related Experiment Video

Updated: May 30, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

ErbB2 down-regulates microRNA-205 in breast cancer

Ryohei Adachi1, Shota Horiuchi, Yoshiyuki Sakurazawa

  • 1Department of Public Health, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Japan.

Biochemical and Biophysical Research Communications
|July 27, 2011
PubMed

Insights

Overexpression of erbB2 in breast cancer downregulates microRNA-205 (miR-205), promoting tumor growth. Restoring miR-205 levels may offer a new therapeutic strategy for erbB2-positive breast cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Gene amplification and protein overexpression of erbB2 (Her2/neu) occur in 20-30% of breast cancers.
  • ErbB2-positive breast cancer is often more aggressive, necessitating research into its signaling pathways for therapeutic targets.

Purpose of the Study:

  • To investigate the relationship between erbB2 overexpression and microRNA-205 (miR-205) expression in breast cancer.
  • To explore the role of miR-205 in erbB2-induced tumorigenesis and its potential as a therapeutic target.

Main Methods:

  • Exogenous overexpression of erbB2 in breast epithelial cells.
  • Transfection of erbB2 siRNA and miR-205 precursor into cancer cells.
  • Assessment of cell growth, including anchorage-independent growth in soft agar.

Main Results:

  • ErbB2 overexpression led to decreased miR-205 expression and increased expression of cyclins (D1, E) and cyclin-dependent kinases (CDK2, CDK4, CDK6).
  • Reducing erbB2 levels with siRNA partially restored miR-205 expression.
  • Overexpression of erbB2 promoted anchorage-independent cell growth, which was attenuated by miR-205 precursor transfection.

Conclusions:

  • Down-regulation of miR-205 is crucial for erbB2-induced tumorigenesis in breast epithelial cells.
  • miR-205 shows potential as a novel therapeutic target for erbB2-positive breast cancer.

More Related Videos

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...